are glp-1 specialty drugs Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Long-term Success of GLP-1s Hinges

A critical bottleneck remains the lack of robust biomarkers to assess myocardial redox status, predict therapeutic response, or stratify patients (Vukainovi et al., 2023)

Although these dermatological changes are not life-threatening, they frequently contribute to significant psychosocial distress and have been associated with systemic inflammatory activation (70)

Patient counseling must prioritize consistency in nutrition, movement, and hydration for sustainable outcomes

3 Low-Quality Products 3 Low-Quality Products Supplements without FDA registration, GMP certification, or manufacturing standards may contain contaminants